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control, leads to rapidly progressive dystonia-parkinsonism with onset in early childhood, a 73 condition known as Hypermanganesemia with Dystonia 2 (HMNDYT2, OMIM # 617013). In a 74 small number of patients, treatment has been attempted with Mn chelation using intravenous 75 disodium calcium edetate (Na2CaEDTA) similar to a protocol established for HMNDYT1 76 (OMIM # 613280) caused by mutations in SLC30A10, a Mn exporter required for biliary 77 excretion of Mn (Tuschl et al., 1993; Tuschl et al., 2012) . MRI brain imaging of patients with 78 either disorder are indistinguishable; hyperintensity of the basal ganglia, particularly the globus 79 pallidus, and the white matter on T1-weighted imaging is a hallmark of both disorders ( Although an essential trace metal, excess Mn has long been known to act as a neurotoxicant. 87 Environmental Mn overexposure leads to preferential Mn accumulation in the globus pallidus 88 similar to that observed in inherited Mn transporter defects, and causes manganism, a 89
Parkinsonian movement disorder characterised by bradykinesia, akinetic rigidity, and 90 dystonia, accompanied by psychiatric disturbances (Blanc, 2018; Chen et al., 2018) . Despite 91 its recognised role in neurodegenerative disease processes, we lack a deeper understanding 92 of the mechanisms of Mn related neurotoxicity. The clinical similarities between manganism 93
and Parkinson's disease (PD) suggest that dopaminergic signalling is impaired upon Mn 94 toxicity. However, in manganism, dopaminergic neurons within the substantia nigra are intact 95 and response to L-DOPA is poor (Koller et al., 2004) . Glutamatergic excitotoxicity as well as 96 altered gamma-aminobutyric acid (GABA) signalling have also been proposed to underlie Mn 97 associated neurodegeneration (Caito and Aschner, 2015) . Indeed, Mn toxicity is likely 98 mediated by a number of processes including oxidative stress, impaired mitochondrial 99 function, protein misfolding and aggregation, and neuroinflammation (Martinez-Finley et al., 100
2013; Tjalkens et al., 2017) . 101
We have recently established and characterised a zebrafish loss-of-function mutant 102 slc39a14 U801-/that closely resembles the human phenotype with systemic accumulation of Mn, 103 particularly in the brain (Tuschl et al., 2016) . Homozygous mutants develop increased 104 susceptibility to Mn toxicity and impaired locomotor behaviour upon Mn exposure. Mn levels 105
can be lowered through chelation with Na2CaEDTA similar to what is observed in human 106
patients (Troche et al., 2016) . 107
In this study, we used RNA sequencing on individual larvae from an in-cross of heterozygous 108 slc39a14 U801 zebrafish to identify novel potential targets of Mn toxicity. Furthermore, we 109
determined the transcriptional signature elicited in response to MnCl2 treatment in mutant and 110 sibling fish. Our results provide evidence that, in addition to Mn neurotoxicity, partial Mn 111 deficiency that corrects upon Mn treatment is a prominent feature of slc39a14 loss-of-function. 112 We also determined that Ca 2+ dyshomeostasis is a likely key event in both Mn deficiency and 113 overload. Mn neurotoxicity appears to be further associated with activation of the unfolded 114 protein response (UPR), oxidative stress, mitochondrial dysfunction, apoptosis and 115 autophagy, and disruption of lysosomes and proteostasis. 116
117

Materials and Methods
118
Zebrafish husbandry 119
Zebrafish were reared on a 14/10 h light/dark cycle at 28. 5°C 
Preparation of larvae for RNA and DNA extraction 125
The progeny of a single in-cross of slc39a14U801 +/fish were raised under standard 126 conditions. At 2 dpf, the larvae were split into two groups and one group was exposed to 127
MnCl2 added to the fishwater at a concentration of 50 µM. 
Transcript counting 142
DeTCT libraries were generated as described previously (Collins et al., 2015) . Briefly, 300 ng 143 of RNA from each genotyped sample was fragmented and bound to streptavidin beads. The 144
3' ends of the fragmented RNA were pulled down using a biotinylated polyT primer. An RNA 145 oligo containing the partial Illumina adapter 2 was ligated to the 5' end of the bound fragment.
146
The RNA fragment was eluted and reverse transcribed using an anchored oligo dT reverse 147 transcriptase primer containing one of the 96 unique index sequences and part of the quantification of gene expression was determined using the 2 −∆∆Ct method, with elongation 175 factor 1α (ef1α) as a reference gene (Livak and Schmittgen, 2001 ). The following primer 176 sequences were used: ef1α forward 5'GTACTTCTCAGGCTGACTGTG3', reverse 5' 177 ACGATCAGCTGTTTCACTCC3'; bdnf forward 5'AGATCGGCTGGCGGTTTATA3', reverse 178 5'CATTGTGTACACTATCTGCCCC3'; gnat2 forward 5'GCTGGCAGACGTCATCAAAA3', 179 reverse 5'CTCGGTGGGAAGGTAGTCAG3'; hspa5 forward 180 5'GCTGGGCTGAATGTCATGAG3', reverse 5'CAGCAGAGACACGTCAAAGG3'; opn1mw2 181 forward 5'GCTGTCATTTCTGCGTTCCT3', reverse 5'GACCATGCGTGTTACTTCCC3'; 182 pde6h forward 5'CTCGCACCTTCAAGAGCAAG3', reverse 183 5'CATGTCTCCAAACGCTTCCC3'; prph2b forward 5'GCCCTGGTGTCCTACTATGG3', 184
reverse 5'CTCTCGGGATTCTCTGGGTC3'. 185
Optokinetic response (OKR) 186
The OKR was examined using a custom-built rig to track horizontal eye movements in 187 response to whole-field motion stimuli. Larvae at 4 dpf were immobilised in 1.5% agarose in a 188
35 mm petri dish and analysed at 5 dpf. The agarose surrounding the eyes was removed to 189 allow normal eye movements. Sinusoidal gratings with spatial frequencies of 0.05, 0. After dehydration larvae were incubated in a 1:1 ethanol Technovit 7100 solution (1% 200
Hardener 1 in Technovit 7100 basic solution) for 1 h followed by incubation in 100% Technovit 201 solution overnight at room temperature (Heraeus Kulzer, Germany). Larvae were than 202 embedded in plastic moulds in Technovit 7100 polymerization medium and dried at 37°C for 203 1 h. Sections of 3 μm thickness were prepared with a microtome, mounted onto glass slides, 204
and dried at 60°C. Sections were stained with Richardson (Romeis) solution (0.5% Borax, 205 0.5% Azur II, 0.5% Methylene Blue) and slides were mounted with Entellan (Merck, Darmstadt, 206
Germany). Images were taken in the brightfield mode of a BX61 microscope (Olympus). 207
Experimental design and statistical analyses 208
Animals were divided into four experimental groups: unexposed homozygous slc39a14 U801-/-209 mutants and their siblings (wild-type and heterozygous genotypes), and MnCl2 exposed 210
homozygous slc39a14 U801-/mutants and their siblings (wild-type and heterozygous 211 genotypes). For the DeTCT data, an equal number of wild-type and heterozygous embryos 212
were selected (see Fig. 1 for numbers of embryos for each experimental group). Embryos 213
were all derived from a single cross to minimise the amount of biological variance not caused 214 by the experimental conditions (i.e. genotype and Mn exposure). One wild-type Mn-exposed 215 embryo was excluded from the data after visual inspection of the Principal Component 216
Analysis as it did not group with any of the other samples. DESeq2 was used for differential 217 expression analysis with the following model: ~ genotype + treatment + genotype:treatment.
218
This models the observed counts as a function of the genotype (homozygous vs siblings) and 219 the treatment (Mn exposed vs unexposed) and an interaction between the two and tests for 220 significant parameters using the Wald test with a p value threshold of 0. 05 
Results
233
Transcriptome analysis of slc39a14 U801 mutants identifies increased sensitivity to Mn 234 toxicity and highlights additional Mn deficiency effects in homozygous mutants 235
To investigate the transcriptional profiles of slc39a14 U801-/mutants in the absence and 236 presence of Mn treatment, embryos from a heterozygous in-cross were split into two groups 237
and either raised under standard conditions (later referred to as unexposed), or treated with 238 50 µM MnCl2 from 2 until 5 days post fertilisation (dpf) ( Fig. 1A) . We have previously shown 239 that this concentration elicits a locomotor phenotype in homozygous mutant larvae that is 240 absent in siblings (Tuschl et al., 2016) . We then carried out transcriptional profiling of individual 241 5 dpf larvae using 3' tag sequencing (Collins et al., 2015). Principal Component Analysis 242
(PCA) shows that the samples cluster according to genotype and treatment status ( Fig. 1B) . 243
Analysis of differentially expressed genes between the four conditions produced three large 244
sets of genes where each set had a characteristic expression profile. The first set are genes 245
that are differentially expressed in MnCl2 exposed siblings compared with unexposed siblings 246 ( Fig. 1C , Mn toxicity) and represent a response to an increased concentration of Mn in the 247 embryos. The second set contains genes that show increased sensitivity to Mn in slc39a14 U801-248 /mutants. These are defined as genes that are differentially expressed in MnCl2 exposed 249 mutants compared with unexposed siblings, but not differentially expressed in unexposed 250 mutants compared to unexposed siblings or exposed siblings compared with unexposed 251 siblings ( Fig. 1D , Increased sensitivity). The third set is composed of genes that are 252 differentially expressed in unexposed mutants compared with unexposed siblings (Fig. 1E , 253
Mutant effect). We will now consider these three groups of genes in turn (Table 1) . 254 
258
(A) Diagram of the experiment. Embryos from a slc39a14 U801 heterozygous in-cross were either 259 exposed to 50 µM MnCl2 or left unexposed from 2 to 5 dpf.
(B) Principal Component Analysis of the samples. Principal component (PC) 1 is plotted on the x-axis
261 and PC2 on the y-axis. Samples belonging to the same condition group together. Unexposed sibling 262 embryos are light blue and MnCl2 exposed ones are dark blue. Unexposed mutants are coloured light 263 red and exposed mutants are dark red.
264
(C) Group 1 (Mn toxicity) genes are defined as those with a significant difference between exposed and 265 unexposed siblings (red bar with asterisk). Example plot of normalised counts for the soul5 gene. The
266
colour scheme for C-E is the same as in (B).
267
(D) Group 2 (Increased sensitivity) genes are defined as those with a significant difference between 268 exposed mutants and unexposed siblings (red bar with asterisk) without significant differences in either 269 unexposed mutants or exposed siblings when compared to unexposed siblings (black bars labelled 270 NS).
271
(E) Group3 (Mutant effect) is defined as genes with a significant difference between unexposed mutants 272 and unexposed siblings (red bar with asterisk).
274
Mn toxicity independent of the genotype 
275
Red, increased gene expression. Blue, reduced gene expression.
Mn toxicity causes differential gene expression independent from the genotype 277
MnCl2 treatment caused differential expression of 328 genes independent of the genotype 278
(comparing MnCl2 exposed siblings and unexposed siblings) ( Fig. 2A , Table 1 and 279 Supplementary Table 1) . Among them is brain-derived neurotrophic factor (bdnf) encoding a 280
protein that is known to be altered upon Mn exposure (Zou et al., 2014) . In addition, bdnf 281 expression is also diminished in untreated mutants compared to siblings (Fig. 2B) . Given that 282 slc39a14 U801-/mutants show evidence of Mn toxicity already at 5 dpf (increased total Mn and 283 reduced locomotor activity), this suggests that bdnf expression is a sensitive read-out for Mn 284 toxicity. Mn associated suppression of BDNF signalling has been linked to diminished 285 numbers of parvalbumin positive cells, mainly GABAergic interneurons (Fairless et al., 2019) . 286
Indeed, we find Parvalbumin encoding genes differentially expressed upon Mn exposure in 287 mutants as well as siblings (pvalb2, pvalb8) and in treated mutants only (pvalb1). However, 288
parvalbumin mRNA expression is upregulated in response to Mn in mutants and siblings, 289
which is unexpected given the previously reported link to reduced numbers of Parvalbumin 290 positive cells. our transcriptome analysis confirms that Mn exposure in zebrafish leads to reduced 299 expression of multiple connective tissue related genes (col2a1b, col4a5, col9a1a, col9a2, 300 col11a2, dcn, fbn2b, matn1). 301
Analysis of annotations to Gene Ontology (GO) terms shows enrichments of terms related to 302 lipid metabolism (apoa4b.2, apoa4a, apoea), blood cell development (alas1, fech, soul5; Fig.  303 1C) and translation (35 ribosomal protein encoding genes) ( Fig. 2C ; Supplementary Table 2) .
304
Mn has previously been shown to interfere with heme-enzyme biogenesis and protein 
309
(A) Heatmap of the expression of all 328 genes with a significant difference between exposed and 310 unexposed siblings (Group 1 -Mn toxicity, Supplementary Table 1) Our analysis showed that 613 genes are differentially expressed in MnCl2 exposed mutants 326 compared with unexposed siblings, with no significant expression changes in either 327
unexposed mutants or exposed siblings. Therefore, these are genes that show increased 328 sensitivity to MnCl2 exposure in slc39a14 U801-/mutant larvae (Fig. 3A) . 15% (95/613) of these 329
genes also have a significant genotype-treatment interaction effect meaning that there is a 330 synergistic effect on expression of treating mutant embryos with MnCl2i.e. the combined 331 estimated effects of genotype and MnCl2 treatment alone are significantly less than the 332 estimated log2 fold change for MnCl2 exposed mutants when compared to unexposed siblings 333 ( Fig. 3B , Table 1 and Supplementary Table 1 ). The remaining genes (518/613) show 334 expression changes consistent with additive effects of the sub-significance threshold 335
responses to genotype and MnCl2 exposure alone (Fig. 3C) . Results from the transcriptome 336 analysis were validated by qRT-PCR for a subset of six genes (bdnf, gnat2, hspa5, opn1mw2, 337 pde6h, prph2b) using RNA extracted from equivalent embryos in a different experiment ( Fig.  338 3D-E, Supplementary Fig. 1 and Supplementary Table 3) . Changes in gene expression 339 observed by qRT-PCR for all six genes were consistent with the results obtained from 340 transcript counting (compare, for instance, Fig. 1D with Fig. 3E and Fig. 3B with Fig. 3D ). 341
Enrichment of zebrafish anatomy (ZFA) terms shows that genes differentially expressed upon 342
MnCl2 exposure in slc39a14 U801-/mutants are disproportionately expressed in the eye and 343
nervous system ( Fig. 3F ; Supplementary Table 4 ). This is confirmed by the enrichment of GO 344 terms such as visual perception and phototransduction. Also enriched are terms related to the 345 ribosome, translation and the unfolded protein response (UPR) suggesting effects on protein 346 production and folding ( Fig. 3G and Supplementary Table 2) . 347 348 349 350 blue and MnCl2 exposed ones are dark blue. Unexposed mutants are coloured light red and exposed 360 mutants are dark red.
361
(C) Example of a gene (pde6c) that has an additive effect of treatment and genotype. The two sub-362 threshold effects of treatment and genotype produce the difference between exposed mutants and 363 unexposed siblings when added together. Colour scheme as in (B). Enriched ZFA terms identified in MnCl2 exposed slc39a14 U801-/mutants that are not present 380
(D-E) qRT-PCR shows comparable gene expression changes as for the single embryo sequencing
in siblings confirm a high number of differentially expressed genes in the nervous system 381
( Supplementary Table 4 and aggregated proteins occurs via the ubiquitin-proteasome system within the cytosol 419 (Tamas et al., 2014 ) and MnCl2 exposed slc39a14 U801-/mutants show gene expression 420 changes linked to ubiquitination (Table 1) . 421
Oxidative stress and mitochondrial dysfunction are prominent features of Mn toxicity (Smith et 422 al., 2017; Harischandra et al., 2019a) . Consistent with this observation, essential genes of the 423 thioredoxin/peroxiredoxin system (prdx1, txn, txnrd3) are activated in MnCl2 exposed 424 slc39a14 U801-/mutants. Likewise, genes related to mitochondrial function show differential 425 expression in MnCl2 treated mutants (Table 1) . 426
As suggested by GO analysis, we observed pronounced expression changes of genes 427 associated with ribosomal function and translation. MnCl2 treatment of slc39a14 U801-/mutants 428 led to differential expression of eleven genes encoding tRNA synthetases, seven genes 429 encoding translation initiation factors and six genes encoding ribosomal proteins. As 430 mentioned above, Mn toxicity independent of the genotype led to differential expression of 431 additional 33 ribosomal protein encoding genes suggesting that protein synthesis is a 432 prominent target of Mn toxicity. 433
434
Increased sensitivity of slc39a14 U801-/mutants to MnCl2 treatment manifests as impaired 435 vision 436 30 genes involved in phototransduction were differentially expressed in MnCl2 exposed 437 mutants but not in siblings ( Fig. 4A, Supplementary Table 1 ). Hence, we further examined the 438 vision of slc39a14 U801-/mutants. Raising slc39a14 U801-/mutant embryos/larvae on a 14 hour 439 light, 10 hour dark cycle revealed absent visual background adaptation upon MnCl2 exposure 440 while exposed wild-type larvae and unexposed mutants showed normal pigmentation (Fig.  441  4B) . Visual background adaptation requires normal vision and is therefore impaired in blind 442
larvae (Le et al., 2012) . To determine whether slc39a14 U801-/larvae develop visual impairment, 443
the optokinetic response (OKR) was analysed in homozygous slc39a14 U801-/larvae at 5 dpf 444 after MnCl2 exposure. Exposed mutant larvae demonstrated a significant reduction in slow 445 phase eye velocity at high spatial frequencies (Fig. 4C) . Therefore, as predicted from the 446 observed gene expression changes, Mn exposure leads to visual impairment and subsequent 447 diminished visual background adaptation. Retinal histology appeared normal suggesting 448 functional rather than overt structural deficits (Fig. 4D) . 449 to the U801 mutation alone (unexposed mutants versus unexposed siblings) ( Fig. 5A;  470 Supplementary table 1). Expression of 12% of these genes (31/266) is also significantly 471 different between MnCl2 exposed mutants and unexposed siblings (Fig. 5B ). Seven of these 472 genes overlap with those differentially expressed in siblings upon MnCl2 exposure suggesting 473 that these genes are sensitive targets of Mn toxicity (alas1, atp2a1, bdnf, crim1, dio3b, dip2ca, 474 rims2b). However, the majority (88%, 235/266) of differentially expressed genes in unexposed 475 mutants are not significantly differentially expressed when comparing MnCl2 exposed mutants 476
and unexposed siblings (Fig. 5C ). This suggests that the U801 mutation creates Mn deficiency 477
leading to gene expression changes that are rescued by MnCl2 treatment towards levels 478 observed in unexposed siblings. 479
Zebrafish anatomy (ZFA) terms for the nervous system are enriched in this set of genes ( Fig.  480 5D; Supplementary Table 4 ) and there is an enrichment for the GO terms cell-cell morphology, 481
adhesion and cell-cell interactions (cadm3, cdh24b, ctnnb1, fhod3b, fnbp1a, fnbp4, nlgn2b,  482 nrcama, nrxn3a pcdh1a, pcdh2g17, pcdh7b, pcdh9, pcdh10a, pcdh17) ( Fig. 5E ; 483
Supplementary Table 2) . Other brain expressed genes that change upon Mn deficiency 484 include some essential for synaptic function and vesicle formation (snap25a, sv2a, sypb, 485 syt6a, syt9a), neurite and axonal growth (dock3, gas7a, kalrna, kalrnb, lrrc4c) and potassium 486 channels (kcnc1a, kcnc3a). 487
In addition, a group of differentially expressed Ca 2+ associated genes are rescued by Mn 488 treatment that is different to that observed upon Mn toxicity. These include genes encoding 489
Ca 2+ ATPases (atp2a1, atp2b3b), Ca 2+ channels (cacnb4b), Ca 2+ activated potassium 490 channels (kcnma1a, kcnn1a), calmodulins (calm1b, calm3a) and calmodulin binding proteins 491 (camta1b, strn4). Similarly, expression changes of genes involved in proteostasis and 492 ubiquitination are observed in both Mn deficiency and toxicity, with a distinct affected gene set 493 for each condition (Table 1) . 
498
(A) Heatmap of the expression of 266 genes with a significant difference between unexposed mutants 499 and unexposed siblings. Each row represents a different gene and each column is a sample. The 500 normalised counts for each gene have been mean centred and scaled by dividing by the standard 501 deviation.
502
(B) Plot of normalised counts for the add2 gene. Expression is decreased in both unexposed and MnCl2 503 exposed mutant embryos. Unexposed sibling embryos are light blue and Mn-exposed ones are dark 504 blue. Unexposed mutants are coloured light red and exposed mutants are dark red. 
518 519
Both Mn toxicity and deficiency in slc39a14 U801-/mutants target the central nervous 520 system 521
We analysed the three different gene sets for transcription factor motif enrichment using 522 HOMER (Fig. 6A) . The only enriched motifs we could identify were from the largest gene set 523 identified in slc39a14 U801-/mutants upon MnCl2 treatment that were unchanged in treated 524 siblings. The motifs included Chop/Atf4 which are part of the unfolded protein response 525
(UPR), as well as HLF, NFIL3 and CEBP:AP1 ( Supplementary Table 5 ). We next examined 526 the enriched Zebrafish Anatomy Ontology (ZFA) terms for each gene set to identify tissue 527 specificity of the observed gene expression changes (Fig. 6B ). Whereas differentially 528
expressed genes due to Mn toxicity effects independent of the genotype showed enrichment 529
of ZFA terms primarily associated with liver and gut, the genes with differential expression 530 due to Mn deficiency and increased sensitivity to Mn in slc39a14 U801-/mutants showed 531 enrichment for the central nervous system ( Supplementary Table 4 ). Consistent with the neurodegenerative phenotype observed in HMNDYT2 patients and the 549 previously described accumulation of Mn in the brain of slc39a14 U801-/mutants (Tuschl et al., 550 2016), the majority of differentially expressed genes map to the CNS and the eye.
551
Transcriptome analysis showed that Mn treatment leads to gene expression changes in both 552 slc39a14 U801-/mutant and sibling zebrafish. Mutant larvae show differential expression of a 553 much greater number of genes upon MnCl2 treatment that is not observed in treated siblings 554
confirming an increased sensitivity to Mn toxicity. In addition, numerous differentially 555 expressed genes in unexposed slc39a14 U801-/mutants normalised upon MnCl2 treatment. This 556
suggests that Mn treatment in slc39a14 U801-/mutants rescues some of the transcriptomic 557 changes observed in unexposed mutants. This implies that SLC39A14 loss leads to Mn 558 deficiency in parallel to the observed Mn accumulation. 559
Loss of slc39a14 function in zebrafish causes Mn deficiency 560
Perhaps the most intriguing observation from the transcriptional profiling was that most 561 differentially expressed genes in unexposed slc39a14 U801-/mutants normalised upon MnCl2 562 treatment. This indicates that whilst SLC39A14 deficiency leads to systemic Mn accumulation 563
in some locations it also causes deficiency of Mn in some parts of the cell or specific types of 564 cells due to its role as a Mn uptake transporter. One implication from this conclusion is that in 565 patients, Mn chelation treatment would require careful monitoring in order to prevent over- 
Mn toxicity interferes with protein synthesis and metabolism 699
As suggested by GO term enrichment analysis, MnCl2 exposure led to differential expression 700 of multiple genes encoding ribosomal proteins, tRNA synthetases and translation initiation 701 factors in slc39a14 U801-/mutants. plays an essential role in retinal function where it is required for normal ultrastructure of the 722 retina (Gong and Amemiya, 1996) . Possible differences between the human and zebrafish 723 phenotype may simply be caused by the direct contact of the zebrafish eye with Mn in the 724 fishwater contributing to enhanced ocular Mn uptake and toxicity. 725
In conclusion, our results demonstrate that partial Mn deficiency is an additional key feature 726 of slc39a14 deficiency in zebrafish which should be considered in the treatment of affected 727
individuals with SLC39A14 mutations. The slc39a14 U801 loss-of-function zebrafish mutant is 728
proving an invaluable disease model to study the disease pathogenesis of HMNDYT2 as well 729
as Mn neurotoxicity in general. 730
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